{
    "2019-01-28": [
        [
            {
                "time": "2018-12-31",
                "original_text": "AbbVie Missed Revenue Estimates in Q4 2018",
                "features": {
                    "keywords": [
                        "Missed",
                        "Revenue",
                        "Estimates",
                        "Q4"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-01-28",
                "original_text": "Health Care Sector Update for 01/28/2019: ABBV, ALXN, TRVN, ARAY",
                "features": {
                    "keywords": [
                        "Health",
                        "Care",
                        "Sector",
                        "Update"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-28",
                "original_text": "What Are Analysts Recommending for AbbVie after Q4 2018 Results?",
                "features": {
                    "keywords": [
                        "Analysts",
                        "Recommending",
                        "AbbVie",
                        "Q4",
                        "Results"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-01-28",
                "original_text": "Monday Sector Laggards: Energy, Healthcare",
                "features": {
                    "keywords": [
                        "Sector",
                        "Laggards",
                        "Energy",
                        "Healthcare"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "energy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-01-29",
                "original_text": "Drug/Biotech Stock Earnings on Jan 29: PFE, AMGN, BIIB & AGN",
                "features": {
                    "keywords": [
                        "Drug",
                        "Biotech",
                        "Stock",
                        "Earnings"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-29",
                "original_text": "Is AbbVie in Hot Water?",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Hot",
                        "Water"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-01-29",
                "original_text": "This is Why AbbVie (ABBV) is a Great Dividend Stock",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Dividend",
                        "Stock"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-29",
                "original_text": "The Zacks Analyst Blog Highlights: J&J, Bristol-Myers, Lilly, AbbVie and Merck",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Analyst",
                        "Blog",
                        "Highlights"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-29",
                "original_text": "Analysts Cut AbbVie Price Targets After Earnings Miss",
                "features": {
                    "keywords": [
                        "Analysts",
                        "Cut",
                        "AbbVie",
                        "Price",
                        "Targets",
                        "Earnings",
                        "Miss"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-01-29",
                "original_text": "5 Dividend Growth Stocks With Upside To Analyst Targets",
                "features": {
                    "keywords": [
                        "Dividend",
                        "Growth",
                        "Stocks",
                        "Upside",
                        "Analyst",
                        "Targets"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-29",
                "original_text": "Health Care Sector Update for 01/28/2019: TRVN, ARAY, ABBV, JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "Health",
                        "Care",
                        "Sector",
                        "Update"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-29",
                "original_text": "AbbVie Announces U.S. FDA Approval of IMBRUVICA® (ibrutinib) Plus Obinutuzumab (GAZYVA®)",
                "features": {
                    "keywords": [
                        "FDA",
                        "Approval",
                        "IMBRUVICA",
                        "Obinutuzumab"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-29",
                "original_text": "AbbVie Falls 3%",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Falls"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-01-29",
                "original_text": "What's Making News In These Pharma And Cannabis Stocks Today?",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Cannabis",
                        "Stocks"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-01-29",
                "original_text": "3 Reasons AbbVie Investors Aren't Too Worried About Humira Anymore",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Investors",
                        "Humira"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}